Abstract
In recent years molecular modeling has emerged as one of the most versatile tool for drug discovery. The In-silico processes not only provide valuable information about interactions between a target protein and a ligand but also accelerate the rate of lead identification. In addition to pharmacodynamic applications, molecular modeling is of paramount importance in determining the pharmacokinetic fate of lead compound also. A wide range of approaches are now available that varies in their computational demand, accuracy and scale of application. Prompted by the successful application of computational drug design in lead identification we have made an effort to identify novel, structurally diverse and druggable anti-leishmanial, anti-malarial and other diseases compounds through pharmacophore based virtual screening.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
